Literature DB >> 4164370

Cerebral blood flow in subarachnoid hemorrhage.

V K Kak, A R Taylor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4164370     DOI: 10.1016/s0140-6736(67)91431-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  SANGUINATE™ (PEGylated Carboxyhemoglobin Bovine) Improves Cerebral Blood Flow to Vulnerable Brain Regions at Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.

Authors:  Rajat Dhar; Hemant Misra; Michael N Diringer
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

2.  Parametric imaging of cerebral vascular reserve. 2. Reproducibility, response to CO2 and correlation with middle cerebral artery velocities.

Authors:  A R Naylor; M V Merrick; J M Slattery; A Notghi; C M Ferrington; J D Miller
Journal:  Eur J Nucl Med       Date:  1991

3.  Cerebral blood flow in patients with subarachnoid haemorrhage studied with an intravenous isotope technique. Its clinical significance in the timing of surgery of cerebral arterial aneurysm.

Authors:  B W Nilsson
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

4.  A feasibility study of a screening test for abnormalities of carotid blood flow using Technetium-99m.

Authors:  K E Britton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-10       Impact factor: 10.154

5.  Experimental studies on the cerebral circulation: clinical aspects.

Authors:  W B Jennett
Journal:  Proc R Soc Med       Date:  1968-06

6.  Relationship between volume flow and velocity in the cerebral circulation.

Authors:  J O Rowan; A M Harper; J D Miller; G M Tedeschi; W B Jennett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-12       Impact factor: 10.154

7.  Limitations of circulation time in the diagnosis of intracranial disease.

Authors:  J O Rowan; J N Cross; G M Tedeschi; W B Jennett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-12       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.